
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $225.3M | -- | -- | $0.65 | -- |
08/01/2025 | Q2 | $198.7M | -- | -- | $0.11 | -- |
05/06/2025 | Q1 | $140.1M | $148.8M | -$0.54 | -- | -- |
02/27/2025 | Q4 | $183M | $188.3M | $0.03 | -- | -- |
10/31/2024 | Q3 | $212.1M | $232.7M | $0.73 | $0.43 | $0.30 |
08/02/2024 | Q2 | $163.8M | $176M | -$0.64 | $0.03 | -$0.67 |
05/02/2024 | Q1 | $137.6M | $138.5M | -$0.38 | -$0.39 | $0.01 |
02/29/2024 | Q4 | $154.5M | $161.5M | -$0.05 | -- | -- |
11/01/2023 | Q3 | $206.5M | $208.8M | $0.32 | $0.34 | -$0.02 |
08/02/2023 | Q2 | $198.7M | $207M | $0.35 | $0.29 | $0.06 |
05/04/2023 | Q1 | -- | $152.3M | -$0.31 | -- | -- |
03/02/2023 | Q4 | -- | $162.9M | -$0.30 | -- | -- |
11/03/2022 | Q3 | -- | $183.7M | $0.10 | -- | -- |
08/03/2022 | Q2 | -- | $198.6M | $0.24 | -- | -- |
05/05/2022 | Q1 | -- | $132.2M | -$0.48 | -- | -- |
03/03/2022 | Q4 | -- | $169M | $0.18 | -- | -- |
11/03/2021 | Q3 | -- | $145.9M | $0.06 | -- | -- |
08/04/2021 | Q2 | -- | $92.5M | -$0.76 | -- | -- |
05/05/2021 | Q1 | -- | $50.8M | -$0.93 | -- | -- |
03/04/2021 | Q4 | -- | $36.7M | -$1.29 | -- | -- |
11/03/2020 | Q3 | -- | $33.6M | -$1.30 | -- | -- |
08/04/2020 | Q2 | -- | $7.9M | -$0.89 | -- | -- |
05/05/2020 | Q1 | -- | $159.5M | -$0.64 | -- | -- |
02/20/2020 | Q4 | -- | $206.9M | $0.25 | -- | -- |
10/24/2019 | Q3 | -- | $211.5M | $0.46 | -- | -- |
07/25/2019 | Q2 | -- | $232.5M | $0.58 | -- | -- |
04/25/2019 | Q1 | -- | $170M | $0.06 | -- | -- |
02/21/2019 | Q4 | -- | $175M | $0.30 | -- | -- |
10/25/2018 | Q3 | -- | $170.6M | $0.56 | -- | -- |
07/26/2018 | Q2 | -- | $193.3M | $0.65 | -- | -- |
04/26/2018 | Q1 | -- | $168.2M | $0.35 | -- | -- |
02/22/2018 | Q4 | -- | $165.6M | $1.21 | -- | -- |
10/26/2017 | Q3 | -- | $162.4M | $0.39 | -- | -- |
07/27/2017 | Q2 | -- | $160.1M | $0.36 | -- | -- |
04/27/2017 | Q1 | -- | $165.5M | $0.33 | -- | -- |
02/23/2017 | Q4 | -- | $169.2M | $0.31 | -- | -- |
10/27/2016 | Q3 | -- | $144.7M | $0.51 | -- | -- |
07/28/2016 | Q2 | -- | $135M | $0.34 | -- | -- |
04/28/2016 | Q1 | -- | $125.4M | $0.20 | -- | -- |
12/17/2015 | Q4 | -- | $115.7M | $0.18 | -- | -- |
09/17/2015 | Q3 | -- | $149.2M | $0.53 | -- | -- |
Marcus reported $148.8M worth of top line sales in its most recent quarter.
Marcus announced earnings per share of -$0.54 which represents a miss of analyst forecast a -- per share.
Marcus reported $47.3M that represents $1.50 per share over the last quarter.
Marcus's earnings are forecast to decrease from -$0.25 per share to -$0.71 per share next year representing a decrease of -84.78%.
Marcus's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.